A new trading day began on Monday, with Agios Pharmaceuticals Inc (NASDAQ: AGIO) stock price up 3.29% from the previous day of trading, before settling in for the closing price of $55.68. AGIO’s price has ranged from $20.96 to $62.58 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 2.66%. Meanwhile, its annual earnings per share averaged 281.41%. With a float of $55.13 million, this company’s outstanding shares have now reached $55.95 million.
Let’s determine the extent of company efficiency that accounts for 383 employees. In terms of profitability, gross margin is 76.16%, operating margin of -1238.1%, and the pretax margin is 2212.98%.
Agios Pharmaceuticals Inc (AGIO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Agios Pharmaceuticals Inc is 3.32%, while institutional ownership is 104.87%. The most recent insider transaction that took place on Nov 08 ’24, was worth 43,301. In this transaction Principal Accounting Officer of this company sold 772 shares at a rate of $56.09, taking the stock ownership to the 813 shares. Before that another transaction happened on Nov 08 ’24, when Company’s Director sold 10,000 for $58.19, making the entire transaction worth $581,911. This insider now owns 7,992 shares in total.
Agios Pharmaceuticals Inc (AGIO) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.72 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.7 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 281.41% per share during the next fiscal year.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
Here are Agios Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 100.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.37, a number that is poised to hit -1.68 in the next quarter and is forecasted to reach -6.08 in one year’s time.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
Looking closely at Agios Pharmaceuticals Inc (NASDAQ: AGIO), its last 5-days average volume was 0.46 million, which is a drop from its year-to-date volume of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 48.38%. Additionally, its Average True Range was 2.41.
During the past 100 days, Agios Pharmaceuticals Inc’s (AGIO) raw stochastic average was set at 77.61%, which indicates a significant increase from 65.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.51% in the past 14 days, which was higher than the 42.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $47.66, while its 200-day Moving Average is $40.43. However, in the short run, Agios Pharmaceuticals Inc’s stock first resistance to watch stands at $58.50. Second resistance stands at $59.49. The third major resistance level sits at $60.72. If the price goes on to break the first support level at $56.27, it is likely to go to the next support level at $55.04. Should the price break the second support level, the third support level stands at $54.05.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Key Stats
With a market capitalization of 3.29 billion, the company has a total of 57,030K Shares Outstanding. Currently, annual sales are 26,820 K while annual income is -352,090 K. The company’s previous quarter sales were 8,960 K while its latest quarter income was 947,920 K.
